Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Longevity pharma and RAIN treasury Enlivex secures $21 million debt financing

Longevity pharma and RAIN treasury Enlivex secures $21 million debt financing

The BlockThe Block2026/03/24 14:39
By:The Block

Enlivex, a Nasdaq-listed longevity company doubling as a RAIN digital asset treasury, said Tuesday it has secured $21 million in debt financing.

The company struck the financing deal with New York-based The Lind Partners, an institutional fund manager, according to a statement.

"We are continuing to execute our prediction markets treasury strategy, and we are pleased that Lind provided us with substantial capital, allowing us to continue the execution of our operating plan, as well as to acquire approximately three billion additional RAIN tokens," Enlivex Executive Chairman Shai Novik said.

In November, Enlivex said it planned to raise $212 million through a private investment in public equity (PIPE) to launch a RAIN token digital asset treasury. The company said it would become the first DAT built around a prediction-markets token.

Rain is self-described as "a fully decentralized prediction markets protocol" on the Arbitrum network. It provides users with the ability to create markets and trade custom options on any event in any language using AI-resolved outcomes and a buyback-and-burn mechanism tied to the RAIN token.

Enlivex's shares, ticker symbol ENLV, were down about 5%, at $1.05 per share, in early trading on Tuesday, according to Yahoo Finance.


0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Betting on individual stocks by the hour: Wall Street leveraged ETF evolves again

Defiance ETFs has applied to the SEC to launch a leveraged fund with hourly resets, rebalancing six times each trading day and shortening the return target period from "daily" to "hourly." This product offers active traders more precise intraday trading tools, but frequent compounding will simultaneously magnify both gains and losses, further increasing volatility risk. Against the backdrop of heightened scrutiny of leveraged ETFs by global regulators, there is significant uncertainty as to whether the product will be approved.

华尔街见闻2026/09/09 16:16